Arjun Balar at [NYU Langone Medical Center]

Arjun V. Balar, MD

About Me

Conditions and Treatments

bladder cancer, testicular cancer, prostate cancer, kidney cancer, cancer chemotherapy, immunotherapy, adrenal tumor

Credentials

Positions
  • Assistant Professor, Department of Medicine
  • Co-Leader Genitourinary Cancers Program
Board Certifications
  • American Board of Internal Medicine (Medical Oncology), 2012
  • American Board of Internal Medicine - Internal Medicine, 2010
Education and Training
  • Fellowship, Memorial Sloan-Kettering Cancer Center, Medical Oncology, 2012
  • Residency, New York Presbyterian-Weill Cornell Med Ctr, Internal Medicine, 2009
  • MD from University Of South Florida, 2006
Departments

Locations and Appointments

67 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Agewell
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthSmart (WTC)
  • Healthfirst
  • Humana Medicare
  • ICSNY
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NYS Empire Plan
  • Oscar
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Village Caremax
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
  • Wellcare Exchange
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Medical Oncology Associates

160 East 34th Street
New York, NY 10016

Contact

Phone: 212-731-5820

NYU Urology Associates

135 East 31st Street, 2nd Floor
New York, NY 10016

NYU Medical Oncology Associates

160 East 34th Street, 10th Floor
New York, NY 10016

Contact

Phone: 212-731-6000

NYU Medical Oncology Associates

160 East 34th Street
New York, NY 10016

Contact

Phone: 212-731-6000

NYU Urology Associates

150 East 32nd Street, 2nd Floor
New York, NY 10016

Contact

Phone: 646-825-6300

NYU Medical Oncology Associates

550 1st Avenue
New York, NY 10016

Contact

Phone: 212-652-1922

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Publications

  • Cytotoxic and DNA-targeted therapy in urothelial cancer: Have we squeezed the lemon enough?

    Balar, Arjun V; Milowsky, Matthew I
    Cancer. 2015 Jan. 121 (2): 179-187

  • The Borealis-2 clinical trial: A randomized phase 2 study of OGX-427 (Apatorsen) plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer. [Meeting Abstract]

    Choueiri, Toni K; Hahn, Noah M; Alva, Ajjai Shivaram; Lauer, Richard C; Dreicer, Robert; Picus, Joel; Pili, Roberto; Balar, Arjun Vasant; Sonpavde, Guru; Hoffman-Censits, Jean H; Guancial, Elizabeth A; Alter, Robert; Regan, Meredith M; Jacobs, Cindy; Stewart, Patricia S; Pal, Sumanta Kumar; Rosenberg, Jonathan E
    Journal of clinical oncology. 2015 MAY 20. 33 (15): ?-?

  • Efficacy and Safety of Selective Vascular Endothelial Growth Factor Receptor Inhibitors Compared with Sorafenib for Metastatic Renal Cell Carcinoma: a Meta-analysis of Randomised Controlled Trials

    Kang, S K; Volodarskiy, A; Ohmann, E L; Balar, A V; Bangalore, S
    Clinical oncology (Royal College of Radiologists). 2015 Dec. ?-?

Read All Publications (15)